Synconadata as at: 18/02/2020
|Objective||To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.|
|Management group||Syncona Investment Managers|
|AIC sector||Biotechnology & Healthcare|
This company is not currently a member of the AIC. We are therefore unable to provide full company information at this time.